Literature DB >> 12960548

Model predictions of gas embolism growth and reabsorption during xenon anesthesia.

Naomi Sta Maria1, David M Eckmann.   

Abstract

BACKGROUND: It is not readily obvious whether an intravascular bubble will grow or shrink in a particular tissue bed. This depends on the constituent gases initially present in the bubble, the surrounding tissue, and the delivered gas admixture. The authors used a computational model based on the physics of gas exchange to predict cerebrovascular embolism behavior during xenon anesthesia.
METHODS: The authors estimated values of gas transport parameters missing from the literature. The computational model was used with those parameters to predict bubble size over time for a range of temperatures (18 degrees -39 degrees C) used during extracorporeal circulation.
RESULTS: Bubble size over time is highly nonlinearly dependent on multiple factors, including diffusivity, solubility, gas partial pressures, magnitude of concentration gradients, vessel diameter, and temperature. Xenon- and oxygen-containing bubbles continue to grow during xenon delivery. Bubble volume doubles from 50 to 100 nl in approximately 3-68 min, depending on initial gas composition and bubble shape. Bubble growth and reabsorption are relatively insensitive to temperature in the physiologic and surgical range.
CONCLUSIONS: Xenon anesthesia results in gas exchange conditions that favor bubble growth, which may worsen neurologic injury from gas embolism. The concentration gradients can be manipulated by discontinuation of xenon delivery to promote reabsorption of xenon-containing bubbles. Estimated growth and reabsorption rates at normothermia can be applied to temperature extremes of cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960548     DOI: 10.1097/00000542-200309000-00019

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  Hyperpolarized (129)Xe MRI: a viable functional lung imaging modality?

Authors:  Samuel Patz; F William Hersman; Iga Muradian; Mirko I Hrovat; Iulian C Ruset; Stephen Ketel; Francine Jacobson; George P Topulos; Hiroto Hatabu; James P Butler
Journal:  Eur J Radiol       Date:  2007-09-24       Impact factor: 3.528

2.  Single-breath xenon polarization transfer contrast (SB-XTC): implementation and initial results in healthy humans.

Authors:  Iga Muradyan; James P Butler; Mikayel Dabaghyan; Mirko Hrovat; Isabel Dregely; Iulian Ruset; George P Topulos; Eric Frederick; Hiroto Hatabu; William F Hersman; Samuel Patz
Journal:  J Magn Reson Imaging       Date:  2012-09-25       Impact factor: 4.813

Review 3.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

4.  Human pulmonary imaging and spectroscopy with hyperpolarized 129Xe at 0.2T.

Authors:  Samuel Patz; Iga Muradian; Mirko I Hrovat; Iulian C Ruset; George Topulos; Silviu D Covrig; Eric Frederick; Hiroto Hatabu; F W Hersman; James P Butler
Journal:  Acad Radiol       Date:  2008-06       Impact factor: 3.173

Review 5.  Polidocanol for endovenous microfoam sclerosant therapy.

Authors:  David M Eckmann
Journal:  Expert Opin Investig Drugs       Date:  2009-12       Impact factor: 6.206

6.  Effects of pulmonary static inflation with 50% xenon on oxygen impairment during cardiopulmonary bypass for stanford type A acute aortic dissection: A pilot study.

Authors:  Mu Jin; Yanwei Yang; Xudong Pan; Jiakai Lu; Zhiquan Zhang; Weiping Cheng
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.